Boston Scientific, J&J On Short List Of Potential Novare Buyers – Firm
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific could target Novare Surgical for acquisition if the start-up's development of a surgical ablation instrument is successful
You may also be interested in...
ECRI Maze/Mitral Repair Report Underlines Need For Trials Of Maze-Alone
Maze atrial ablation appears to be a valuable adjunct to mitral valve repair surgery in patients with atrial fibrillation (AF); however the value of maze-alone has not been demonstrated, according to a new meta-analysis report from ECRI
ECRI Maze/Mitral Repair Report Underlines Need For Trials Of Maze-Alone
Maze atrial ablation appears to be a valuable adjunct to mitral valve repair surgery in patients with atrial fibrillation (AF); however the value of maze-alone has not been demonstrated, according to a new meta-analysis report from ECRI
Cordis Recruits Guidant To Block Taxus, Develop Combined Delivery System
Johnson & Johnson/Cordis is betting that its drug-eluting stent marketing alliance with Guidant will allow it to match Boston Scientific's sales presence in U.S. cath labs